Editorial: Challenges of pharmacoeconomics in global health arena-Contemporary momentum in the early 2020s
- PMID: 37124830
- PMCID: PMC10133688
- DOI: 10.3389/fpubh.2023.1189671
Editorial: Challenges of pharmacoeconomics in global health arena-Contemporary momentum in the early 2020s
Keywords: costs; drugs; global; medicines; pharmaceutical expenditure; pharmaceutical policy; pharmacoeconomics; reimbursement.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
- Editorial on the Research Topic Challenges of pharmacoeconomics in global health arena—Contemporary momentum in the early 2020s
References
-
- MacQuilkan K, Baker P, Downey L, Ruiz F, Chalkidou K, Prinja S, et al. . Strengthening health technology assessment systems in the global south: a comparative analysis of the HTA journeys of China, India and South Africa. Glob Health Action. (2018) 11:1527556. 10.1080/16549716.2018.1527556 - DOI - PMC - PubMed
-
- OECD . Business Insights on Emerging Markets 2021. In: OECD Emerging Markets Network. Paris: OECD Development Centre. (2021).
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
